InspireMD
NSPR
24 hedge funds and large institutions have $29.9M invested in InspireMD in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
25% more capital invested
Capital invested by funds: $24M → $29.9M (+$5.89M)
4.5% more ownership
Funds ownership: 43.39% → 47.88% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
14% less funds holding
Funds holding: 28 → 24 (-4)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$4.28M |
| 2 |
Morgan Stanley
New York
|
+$59.6K |
| 3 |
FFA
Farther Finance Advisors
San Francisco,
California
|
+$2.34K |
| 4 |
Millennium Management
New York
|
+$225 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$93.4K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$7.11K |
| 3 |
Renaissance Technologies
New York
|
-$3.75K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$2.24K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$258 |
NSPR Hedge Fund Activity: Q2 2024 in Review
24 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q2 2024, worth a combined $29.9M — up 25% from $24M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NSPR and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Rosalind Advisors, adding an estimated $4.28M. The largest seller was Nantahala Capital Management, cutting an estimated $93.4K.
- 24 institutional investors held InspireMD (NSPR) as of Q2 2024, down from 28 in Q1 2024.
- Funds reported $29.9M of InspireMD stock for Q2 2024, up 25% quarter-over-quarter.
- 1 fund opened new InspireMD positions in Q2 2024 and 4 closed out, a net change of -3 holders.
- The largest InspireMD buyer in Q2 2024 was Rosalind Advisors, an estimated $4.28M added.
- The largest InspireMD seller in Q2 2024 was Nantahala Capital Management, an estimated $93.4K sold.
Based on aggregated 13F filings for Q2 2024.